Current findings on ALL indicate that glucocorticoid resistance, linked to poorer prognosis, correlates with elevated caspsase-1 and NLRP3 expression, due to reduced methylation of their promoters in leukemia cells [64,65]. The gene discussed is NLRP3; the disease is leukemia.